Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 3
2011 2
2013 2
2014 4
2017 2
2018 2
2019 2
2020 2
2021 1
2022 2
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy.
Barratt J, Lafayette R, Kristensen J, Stone A, Cattran D, Floege J, Tesar V, Trimarchi H, Zhang H, Eren N, Paliege A, Rovin BH; NefIgArd Trial Investigators. Barratt J, et al. Kidney Int. 2023 Feb;103(2):391-402. doi: 10.1016/j.kint.2022.09.017. Epub 2022 Oct 19. Kidney Int. 2023. PMID: 36270561 Free article. Clinical Trial.
[Kidney disease care for the elderly].
Hamroun A, Frimat M, Beuscart JB, Buob D, Lionet A, Lebas C, Daroux M, Provôt F, Hazzan M, Boulanger É, Glowacki F. Hamroun A, et al. Among authors: daroux m. Nephrol Ther. 2019 Dec;15(7):533-552. doi: 10.1016/j.nephro.2019.10.001. Epub 2019 Nov 9. Nephrol Ther. 2019. PMID: 31711751 Review. French.
Prognostic value of complement serum C3 level and glomerular C3 deposits in anti-glomerular basement membrane disease.
Caillard P, Vigneau C, Halimi JM, Hazzan M, Thervet E, Heitz M, Juillard L, Audard V, Rabant M, Hertig A, Subra JF, Vuiblet V, Guerrot D, Tamain M, Essig M, Lobbedez T, Quemeneur T, Legendre M, Ganea A, Peraldi MN, Vrtovsnik F, Daroux M, Makdassi R, Choukroun G, Titeca-Beauport D. Caillard P, et al. Among authors: daroux m. Front Immunol. 2023 Jul 5;14:1190394. doi: 10.3389/fimmu.2023.1190394. eCollection 2023. Front Immunol. 2023. PMID: 37475859 Free PMC article.
[Cognitive impairment and chronic kidney disease: which links?].
Gaxatte C, Daroux M, Bloch J, Puisieux F, Deramecourt V, Boulanger E. Gaxatte C, et al. Among authors: daroux m. Nephrol Ther. 2011 Feb;7(1):10-7. doi: 10.1016/j.nephro.2010.09.001. Epub 2010 Nov 2. Nephrol Ther. 2011. PMID: 21050832 Review. French.
Early Renal Recovery after the First Flare of Pauci-Immune Glomerulonephritis.
Zaworski J, Gnemmi V, Bataille P, Hachulla E, Glowacki F, Gibier JB, Daroux M, Ratsimbazafy A, Bitton L, Humez S, Guincestre T, Béhal H, Azar R, Hoffmann M, Cardon G, Bourdon F, Lemoine C, Auxenfant E, Copin MC, Vandenbussche C, Quéméneur T; pour la cohorte RENVAS. Zaworski J, et al. Among authors: daroux m. Am J Nephrol. 2022;53(1):59-68. doi: 10.1159/000520285. Epub 2022 Jan 17. Am J Nephrol. 2022. PMID: 35038711
Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions.
Teissier T, Quersin V, Gnemmi V, Daroux M, Howsam M, Delguste F, Lemoine C, Fradin C, Schmidt AM, Cauffiez C, Brousseau T, Glowacki F, Tessier FJ, Boulanger E, Frimat M. Teissier T, et al. Among authors: daroux m. Aging Cell. 2019 Apr;18(2):e12850. doi: 10.1111/acel.12850. Epub 2019 Feb 22. Aging Cell. 2019. PMID: 30794349 Free PMC article.
23 results